Jump to content
Sign in to follow this  
Guest guest

Teresa Binstock: Aluminum in vaccines has widespread effects.

Rate this topic

Recommended Posts

Guest guest

Aluminum in vaccination-associated cognitive decline, motor neuron





Teresa Binstock

Researcher in Developmental & Behavioral Neuroanatomy

September 28, 2009


A recent news article reported that "Cases of [Alzheimer's-like]

dementia explode globally" (1). Almost simultaneously, the Journal

of Inorganic Biochemistry published three articles implicating an

ingredient present in many vaccines, aluminum hydroxide. First, Maryline

Couette and colleagues published "Long-term persistence of

vaccine-derived aluminum hydroxide is associated with chronic cognitive

dysfunction" (2).

Concurrently, Shaw and Petrik reported that "Aluminum hydroxide

injections lead to motor deficits and motor neuron degeneration".

And despite the presumed sanctity of vaccines and vaccinations, the

researchers dared conclude: "The demonstrated neurotoxicity of

aluminum hydroxide and its relative ubiquity as an adjuvant suggest that

greater scrutiny by the scientific community is warranted."


Aluminum hydroxide and other aluminum compounds are a component of

various medications (4-5) and vaccines (eg, 6-10), wherein aluminum

compounds serve as an adjuvant to hyperstimulate immunity (eg, 11).


Importantly, just as aluminum hydroxide is associated with cognitive

decline and with motor neuron pathologies, and aluminum compounds are

present in many vaccines, aluminum has again been found in Alzheimer's

plaques in humans (12).

Dare we ask, Who among us wants to be injected with a substance

associated with cognitive decline, motor neuron disease, and Alzheimer's?


We know who among us wants to inject aluminum compounds along with

thimerosal (eg, 13-14), and squalene (eg, 15-18) under the guise of

protecting our health. But as numbers of people with dementia, rheumatoid

diseases, and autism continue to increase, perhaps time has come to

desanctify vaccinationism, vaccinology, vaccinologists and their

marketing representatives acting within the FDA and CDC.

Using vaccine ingredients to induce pathologies is an unwelcome burden on

affected individuals and their families.



1. Cases of dementia explode globally

More than 35 million live with the incurable ailment,

which is expected to double every 20 years worldwide.

By Lauran Neergaard

The Associated Press, 09/21/2009



2. Long-term persistence of vaccine-derived

aluminum hydroxide is associated with chronic cognitive dysfunction

Maryline Couette et al.

Journal of Inorganic Biochemistry (2009) in press

Macrophagic myofasciitis (MMF) is an emerging condition, characterized by

specific muscle lesions assessing long-term persistence of aluminum

hydroxide within macrophages at the site of previous immunization.

Affected patients mainly complain of arthromyalgias, chronic fatigue, and

cognitive difficulties. We designed a comprehensive battery of

neuropsychological tests to prospectively delineate MMF-associated

cognitive dysfunction (MACD). Compared to control patients with arthritis

and chronic pain, MMF patients had pronounced and specific cognitive

impairment. MACD mainly affected (i) both visual and verbal memory; (ii)

executive functions, including attention, working memory, and planning;

and (iii) left ear extinction at dichotic listening test. Cognitive

deficits did not correlate with pain, fatigue, depression, or disease

duration. Pathophysiological mechanisms underlying MACD remain to be

determined. In conclusion, long-term persistence of vaccine-derived

aluminum hydroxide within the body assessed by MMF is associated with

cognitive dysfunction, not solely due to chronic pain, fatigue and


3. Aluminum hydroxide injections lead to

motor deficits and motor neuron degeneration

Christopher A. Shaw; Michael S. Petrik.

Journal of Inorganic Biochemistry (2009) in press

Gulf War Syndrome is a multi-system disorder afflicting many veterans of

Western armies in the 1990–1991 Gulf War. A number of those afflicted may

show neurological deficits including various cognitive dysfunctions and

motor neuron disease, the latter expression virtually indistinguishable

from classical amyotrophic lateral sclerosis (ALS) except for the age of

onset. This ALS ‘‘cluster†represents the second such ALS cluster

described in the literature to date. Possible causes of GWS include

several of the adjuvants in the anthrax vaccine and others. The most

likely culprit appears to be aluminum hydroxide. In an initial series of

experiments, we examined the potential toxicity of aluminum hydroxide in

male, outbred CD-1 mice injected subcutaneously in two

equivalent-to-human doses. After sacrifice, spinal cord and motor cortex

samples were examined by immunohistochemistry. Aluminum-treated mice

showed significantly increased apoptosis of motor neurons and increases

in reactive astrocytes and microglial proliferation within the spinal

cord and cortex. Morin stain detected the presence of aluminum in the

cytoplasm of motor neurons with some neurons also testing positive for

the presence of hyper-phosphorylated tau protein, a pathological hallmark

of various neurological diseases, including Alzheimer’s disease and

frontotemporal dementia. A second series of experiments was conducted on

mice injected with six doses of aluminum hydroxide. Behavioural analyses

in these mice revealed significant impairments in a number of motor

functions as well as diminished spatial memory capacity. The demonstrated

neurotoxicity of aluminum hydroxide and its relative ubiquity as an

adjuvant suggest that greater scrutiny by the scientific community is


4. Aluminum hydroxide



5. Aluminum hydroxide




6. Vaccine Ingredients...



7. Aluminum Hydroxide in Vaccines





8. Aluminum-hydroxide in vaccines causes

serious health problems

By Tenna Merchant



9. Aluminum: Vaccine Education Center




10. Is Aluminum the New Thimerosal?

By Robert W. Sears

Mothering Magazine; Issue 146, January/February 2008



11. The Common Vaccine Adjuvant Aluminum

Hydroxide Up-Regulates Accessory Properties of Human Monocytes via an

Interleukin-4-Dependent Mechanism

Marina Ulanova et al.

Infect Immun. 2001 February; 69(2): 1151–1159.


http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=97997 & blobtype=pdf


12. Demonstration of aluminum in amyloid

fibers in the cores of senile plaques in the brains of patients with

Alzheimer’s disease

Sakae Yumoto et al.

Journal of Inorganic Biochemistry (2009) in press

Aluminum (Al) exposure has been reported to be a risk factor for

Alzheimer’s disease (senile dementia of Alzheimer type), although the

role of Al in the etiology of Alzheimer’s disease remains controversial.

We examined the presence of Al in the Alzheimer’s brain using

energy-dispersive X-ray spectroscopy combined with transmission electron

microscopy (TEM-EDX). TEM-EDX analysis allows simultaneous imaging of

subcellular structures with high spatial resolution and analysis of small

quantities of elements contained in the same subcellular structures. We

identified senile plaques by observation using TEM and detected Al in

amyloid fibers in the cores of senile plaques located in the hippocampus

and the temporal lobe by EDX. Phosphorus and calcium were also present in

the amyloid fibers. No Al could be detected in the extracellular space in

senile plaques or in the cytoplasm of nerve cells. In this study, we

demonstrated colocalization of Al and beta-amyloid (Abeta) peptides in

amyloid fibers in the cores of senile plaques. The results support the

following possibilities in the brains of patients with Alzheimer’s

disease: Al could be involved in the aggregation of Abeta peptides to

form toxic fibrils; Al might induce Abeta peptides into the beta-sheet

structure; and Al might facilitate iron-mediated oxidative reactions,

which cause severe damage to brain tissues.

13. Hepatitis B triple series vaccine and

developmental disability in US children aged 1-9 years

Gallagher C, Goodman M. Toxicol Environ Chem 2008


{free online}



"The odds of receiving EIS were approximately nine times as great

for vaccinated boys... as for unvaccinated boys..., after adjustment for


14. Hepatitis B vaccination of male neonates

and autism

[conference abstract as published]

CM Gallagher, MS Goodman, Graduate Program in Public

Health, Stony Brook University Medical Center, Stony Brook, NY

Annals of Epidemiology, p659

Vol. 19, No. 9 Abstracts (ACE) September 2009: 651–680

[triple the rate of autism among boys vaccinated with thimerosal versus

boys not so vaccinated]

15. Vaccine A: The Covert Government

Experiment That's Killing Our Soldiers--And Why GI's Are Only The First


Gary Matsumoto, 2004.




16. Squalene & Gulf War illnesses




17. Part 1: H1N1... vaccine and human




18. Part II: Squalene laced H1N1 vaccination






Return to

index of essays by Teresa Binstock www.iamnolabrat.com

From cricket scores to your friends. Try the India Homepage!

Share this post

Link to post
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Sign in to follow this  

  • Create New...